New imaging tool could sharpen prostate cancer treatment decisions

NCT ID NCT06815354

First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 30 times

Summary

This study looks at whether a new imaging analysis tool, called TRAQinform Theranostics, can help doctors make better treatment decisions for people with metastatic prostate cancer. About 32 participants will have their treatment plans compared with and without the tool's report. The goal is to see if the tool changes what doctors decide, not to test a new treatment itself.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • M.D. Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Weill Medical College of Cornell

    RECRUITING

    New York, New York, 10065, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.